Forsta Ap Fonden Abbott Laboratories Transaction History

Forsta Ap Fonden

$13.7 Billion
Q4 2024

A detailed history of Forsta Ap Fonden transactions in Abbott Laboratories stock. As of the latest transaction made, Forsta Ap Fonden holds 421,700 shares of ABT stock, worth $56.9 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

421,700

Previous 422,100 0.09%

Holding current value

$56.9 Million

Previous $48.1 Million 0.88%

% of portfolio

0.35%

Previous 0.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$111.93 - $119.39 $44,772 - $47,756	-400 Reduced 0.09%	421,700 $47.7 Million
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $3.85 Million - $4.55 Million	38,500 Added 10.04%	422,100 $48.1 Million
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $3.09 Million - $3.45 Million	-30,700 Reduced 7.41%	383,600 $39.9 Million
Q1 2024 May 07, 2024	SELL	$109.52 - $120.96 $3.52 Million - $3.88 Million	-32,100 Reduced 7.19%	414,300 $47.1 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $3.54 Million - $4.33 Million	-39,200 Reduced 8.07%	446,400 $49.1 Million
Q3 2023 Oct 25, 2023	BUY	$95.53 - $114.62 $1.25 Million - $1.5 Million	13,100 Added 2.77%	485,600 $47 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $131,014 - $145,977	-1,300 Reduced 0.27%	472,500 $51.5 Million
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $4.92 Million - $5.79 Million	-50,800 Reduced 9.68%	473,800 $48 Million
Q4 2022 Feb 02, 2023	BUY	$95.06 - $111.52 $9.22 Million - $10.8 Million	97,000 Added 22.68%	524,600 $57.6 Million
Q3 2022 Oct 17, 2022	BUY	$96.76 - $112.03 $6.8 Million - $7.88 Million	70,300 Added 19.68%	427,600 $41.4 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $2.3 Million - $2.78 Million	-22,500 Reduced 5.92%	357,300 $38.8 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $34,206 - $41,712	300 Added 0.08%	379,800 $45 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $4.25 Million - $5.21 Million	36,800 Added 10.74%	379,500 $53.4 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $1.25 Million - $1.38 Million	10,700 Added 3.22%	342,700 $40.5 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $4.02 Million - $4.73 Million	38,000 Added 12.93%	332,000 $38.5 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $4.3 Million - $5.07 Million	-39,500 Reduced 11.84%	294,000 $35.2 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $3.48 Million - $3.79 Million	33,100 Added 11.02%	333,500 $36.5 Million
Q3 2020 Oct 22, 2020	BUY	$91.64 - $111.29 $3.54 Million - $4.3 Million	38,600 Added 14.74%	300,400 $32.7 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $2.2 Million - $2.81 Million	28,700 Added 12.31%	261,800 $23.9 Million
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $12.1 Million - $17.7 Million	192,400 Added 472.73%	233,100 $18.4 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $157,020 - $174,800	-2,000 Reduced 4.68%	40,700 $3.54 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $196,416 - $212,976	-2,400 Reduced 5.32%	42,700 $3.57 Million
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $524,736 - $612,000	-7,200 Reduced 13.77%	45,100 $3.79 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $443,674 - $536,402	-6,700 Reduced 11.36%	52,300 $4.18 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $635,932 - $720,419	-9,700 Reduced 14.12%	59,000 $4.27 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $4.18 Million - $5.04 Million	68,700 New	68,700 $5.04 Million
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $3.6 Million - $4.07 Million	-63,900 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $279,136 - $298,844	5,200 Added 8.86%	63,900 $3.65 Million
Q3 2017 Oct 31, 2017	BUY	$48.06 - $53.64 $2.82 Million - $3.15 Million	58,700	58,700 $3.13 Million

Others Institutions Holding ABT

# of Institutions

3,361

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account